Naoki Terakawa
About
In The Last Decade
Naoki Terakawa
252 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Reproductive Medicine 5.3k
- Obstetrics and Gynecology 3.6k
- Molecular Biology 2.2k
- Immunology 2.2k
- Oncology 1.5k
Countries citing papers authored by Naoki Terakawa
This map shows the geographic impact of Naoki Terakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Terakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Terakawa more than expected).
Fields of papers citing papers by Naoki Terakawa
This network shows the impact of papers produced by Naoki Terakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Terakawa. The network helps show where Naoki Terakawa may publish in the future.
Co-authorship network of co-authors of Naoki Terakawa
This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Terakawa. A scholar is included among the top collaborators of Naoki Terakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Terakawa. Naoki Terakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Apigenin inhibits tumor necrosis factor α–induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells | Fertility and Sterility | Fuminori Taniguchi, Naoki Terakawa et al. | 21 |
| 2 | Introduction | Gynecologic and Obstetric Investigation | Hiroshi Hoshiai, Naoki Terakawa | 2 |
| 3 | Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy | Molecular Cancer Therapeutics | Hiroaki Itamochi, Junzo Kigawa et al. | 21 |
| 4 | Ovarian Metastasis in Carcinoma of the Uterine Cervix | Obstetrical & Gynecological Survey | Muneaki Shimada, Junzo Kigawa et al. | 3 |
| 5 | Ultrasound‐guided local injection of methotrexate to treat an invasive hydatidiform mole | Journal of obstetrics and gynaecology research | Tasuku Harada, Naoki Terakawa et al. | 1 |
| 6 | Expression of the c‐myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer | Cancer Science | Junzo Kigawa, Yasunobu Kanamori et al. | 41 |
| 7 | Two cases of clear cell adenocarcinoma of the endometrium. | The Journal of the Japanese Society of Clinical Cytology | Makoto Ohta, Hiroaki Itamochi et al. | 1 |
| 8 | Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian Cancer | Gynecologic Oncology | Shunji Kamazawa, Junzo Kigawa et al. | 99 |
| 9 | Successful Management of Humoral Hypercalcemia of Malignancy in A Patient with Ovarian Cancer | Yonago acta medica | Fuminori Taniguchi, Junzo Kigawa et al. | 3 |
| 10 | Chemosensitivity and p53‐dependent apoptosis in epithelial ovarian carcinoma | Cancer | Junzo Kigawa, Yukihisa Minagawa et al. | 2 |
| 11 | Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma | Cancer | Shinya Sato, Junzo Kigawa et al. | 43 |
| 12 | Expression of c-kitMessenger Ribonucleic Acid in Human Oocyte and Presence of Soluble c-kitin Follicular Fluid | The Journal of Clinical Endocrinology & Metabolism | Masahiro Tanikawa, Tasuku Harada et al. | 40 |
| 13 | Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer. | PubMed | Junzo Kigawa, Y Minagawa et al. | 44 |
| 14 | Cytological endometorial hyperplasia with new classification. Evaluation of endometrial hyperplasia according to WHO classification by cytologic specimen. | The Journal of the Japanese Society of Clinical Cytology | Junzo Kigawa, Yasunobu Kanamori et al. | 2 |
| 15 | Paracrine effects of bFGF and KGF on the process of mouse blastocyst implantation | Molecular Reproduction and Development | Fuminori Taniguchi, Souichi Yoshida et al. | 41 |
| 16 | Autocrine growth mechanism by transforming growth factor (TGF)‐β1 and TGF‐β1‐receptor regulation by epidermal growth factor in a human endometrial cancer cell line IK‐90 | International Journal of Cancer | Masahiro Sakata, Hirohisa Kurachi et al. | 10 |
| 17 | Inhibitory effect of androgen on cell death of mouse uterine epithelium | Journal of Steroid Biochemistry | Nobuyuki Terada, Reiko Yamamoto et al. | 15 |
| 18 | Changes of bioactive luteinizing hormone after laparoscopic ovarian cautery in patients with polycystic ovarian syndrome | Fertility and Sterility | Masahiro Sakata, Keiichi Tasaka et al. | 28 |
| 19 | Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors | Journal of Steroid Biochemistry | Naoki Terakawa, Hiromasa Ikegami et al. | 14 |
| 20 | 213. Changes in Estrogen and Progesterone Receptor in Rat Hypothalamus and Pituitary after the Administration of Clomiphene | 日本産科婦人科學會雜誌 | Naoki Terakawa, Hiromori Tsutsumi et al. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.